Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
This is not Ozempic, Wegovy, or any other brand-name product
The safety profile of Tirzepatide is generally favorable, with mild gastrointestinal side effects such as nausea and vomiting that typically resolve over time
Retatrutide is not licensed by the MHRA and cannot be routinely prescribed through NHS or private routes in the UK
Pharmacologically, lowering hyperglycemia and hyperlipidemia as well as achieving tight blood pressure control is pursued
Usage Recommendations: Fitaro 0.5 mg is suitable for type 2 diabetes patients seeking further glycemic control after maximizing oral antidiabetic therapy
US$ 28.36
US$ 20.06
US$ 24.73
US$ 21.08
